Korro Bio (KRRO) EPS (Basic) Growth (3y) (2021 - 2026)
Korro Bio (KRRO) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 37.73% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 86.43% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 71.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.38% |
| Dec 31, 2025 | -25.84% |
| Sep 30, 2025 | 58.91% |
| Jun 30, 2025 | 55.15% |
| Mar 31, 2025 | 57.98% |
| Dec 31, 2024 | 30.51% |
| Sep 30, 2024 | 60.46% |
| Jun 30, 2024 | 54.50% |
| Mar 31, 2024 | 56.61% |
| Dec 31, 2023 | -1.58% |
| Sep 30, 2023 | -45.83% |
| Jun 30, 2023 | -87.42% |
| Mar 31, 2023 | -108.57% |
| Dec 31, 2022 | 40.24% |
| Sep 30, 2022 | 8.94% |
| Jun 30, 2022 | 43.74% |
| Mar 31, 2022 | 40.81% |
| Dec 31, 2021 | 43.98% |
| Sep 30, 2021 | 39.27% |